This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2uuq

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2uuq.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:2uuq.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2uuq| PDB=2uuq | SCENE= }}
{{STRUCTURE_2uuq| PDB=2uuq | SCENE= }}
-
'''CRYSTAL STRUCTURE OF CYP130 FROM MYCOBACTERIUM TUBERCULOSIS IN THE LIGAND-FREE FORM'''
+
===CRYSTAL STRUCTURE OF CYP130 FROM MYCOBACTERIUM TUBERCULOSIS IN THE LIGAND-FREE FORM===
-
==Overview==
+
<!--
-
CYP130 is one of the 20 Mycobacterium tuberculosis cytochrome P450 enzymes, only two of which, CYP51 and CYP121, have so far been studied as individually expressed proteins. Here we characterize a third heterologously expressed M. tuberculosis cytochrome P450, CYP130, by UV-visible spectroscopy, isothermal titration calorimetry, and x-ray crystallography, including determination of the crystal structures of ligand-free and econazole-bound CYP130 at a resolution of 1.46 and 3.0A(,) respectively. Ligand-free CYP130 crystallizes in an "open" conformation as a monomer, whereas the econazole-bound form crystallizes in a "closed" conformation as a dimer. Conformational changes enabling the "open-closed" transition involve repositioning of the BC-loop and the F and G helices that envelop the inhibitor in the binding site and reshape the protein surface. Crystal structure analysis shows that the portion of the BC-loop relocates as much as 18A between the open and closed conformations. Binding of econazole to CYP130 involves a conformational change and is mediated by both a set of hydrophobic interactions with amino acid residues in the active site and coordination of the heme iron. CYP130 also binds miconazole with virtually the same binding affinity as econazole and clotrimazole and ketoconazole with somewhat lower affinities, which makes it a plausible target for this class of therapeutic drugs. Overall, binding of the azole inhibitors is a sequential two-step, entropy-driven endothermic process. Binding of econazole and clotrimazole exhibits positive cooperativity that may reflect a propensity of CYP130 to associate into a dimeric structure.
+
The line below this paragraph, {{ABSTRACT_PUBMED_18089574}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 18089574 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_18089574}}
==About this Structure==
==About this Structure==
Line 33: Line 37:
[[Category: Oxidoreductase]]
[[Category: Oxidoreductase]]
[[Category: P450]]
[[Category: P450]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 17:31:21 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 15:07:35 2008''

Revision as of 12:07, 28 July 2008

Image:2uuq.png

Template:STRUCTURE 2uuq

CRYSTAL STRUCTURE OF CYP130 FROM MYCOBACTERIUM TUBERCULOSIS IN THE LIGAND-FREE FORM

Template:ABSTRACT PUBMED 18089574

About this Structure

2UUQ is a Single protein structure of sequence from Mycobacterium tuberculosis. Full crystallographic information is available from OCA.

Reference

Mycobacterium tuberculosis CYP130: CRYSTAL STRUCTURE, BIOPHYSICAL CHARACTERIZATION, AND INTERACTIONS WITH ANTIFUNGAL AZOLE DRUGS., Ouellet H, Podust LM, de Montellano PR, J Biol Chem. 2008 Feb 22;283(8):5069-80. Epub 2007 Dec 18. PMID:18089574

Page seeded by OCA on Mon Jul 28 15:07:35 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2uuq"
Personal tools